High Level of Fried Food Toxins Found in Infants
Advanced Glycation End products (AGEs) are found in most heated foods and in commercial infant formulas. Also found, reducing AGEs improves adult diabetes.

‘Genetic Biopsy’ Could Help Pick Best Eggs for IVF
Analyzing genetic material in polar bodies, shed at fertilization, can yield information about gene expression in the egg without disturbing the egg itself.

Sox2 Marks Pluripotency in Most Adult Stem Cells
Sox2 appears to be the only transcription factor appearing in all stem cell stages – embryonic, fetal and adult. It may also indicate pluripotent adult stem cells.

Stem Cell Reprogramming Safer than Thought
Selecting better donor cells and using more sensitive genome-survey techniques allows identifying and reprogramming methods safer than in current use.

October 6, 2011--------News Archive

Invasive Melanoma Higher in Children Than Adults
A study of young people with melanoma, a deadly form of skin cancer, has found that some children have a higher risk of invasive disease than adults.

All Human Egg Donors Should Be Compensated
When you donate your eggs to fertility clinics for infertile parents, you are compensated. But if you donate your eggs for stem research, you are not.

Chronic Stress Short-circuits Some Parents
Moms with higher depressive responses exhibit symptoms of extreme stress with distinct types of problem parenting, from neglect and hostility to insensitivity.

October 5, 2011--------News Archive

Intensive Exposure Best for Reading Difficulties
Intensive daily training for a limited period is better for children with reading and writing difficulties than the traditional remedial tuition offered by schools.

A Shot of Cortisone Will Stop Traumatic Stress!
A single injection of cortisone can prevent PTSD in 60% who experience trauma.

Asthma Guidelines Do Not Reduce Readmissions
Hospital compliance with The Children's Asthma Care (CAC) guidelines makes little difference in a patient's return for another asthma attack.

October 4, 2011--------News Archive

How the Brain Makes Memories: Rhythmically!
The brain learns through changes in the strength of its synapses in response to stimuli. However, the stimulus must be rhythmic - timed at exact intervals.

Anesthesia Exposure Linked to Learning Disability
Research has found a link among children undergoing multiple surgeries requiring general anesthesia before age 2 and learning disabilities later in childhood.

How Vertebrates Establish Left–Right Asymmetry
Although we appear bilaterally symmetrical on the outside, our internal organs are asymmetrically positioned along a left–right axis.

October 3, 2011--------News Archive

Glucosamine-like Supplement Suppresses MS Attacks
UCI study shows promise of metabolic therapy for autoimmune diseases.

Early to Bed and Barly to Rise - Keeps Kids Lean
Bedtime found to be as important for preteens and teens as getting enough sleep.

Discovered: "Flexible" Brain DNA Changes to Suit
Finding has implications for treatment of wide range of diseases.

Mother's Love Unravels Gene Sequencing Mystery
A mother's determination solves the strange symptoms in her twins. Personalized medicine through genome sequencing is working for this family.

Genome Architecture Foretells Genome Instability
In normal cell division, DNA gets copied perfectly and distributed between daughter cells evenly. But occasional breaks during division rearrange the results.

As soldiers return home from tours in Afghanistan and Iraq, America must cope with the toll that war takes on mental health. But the treatment of Post Traumatic Stress Disorder (PTSD) is becoming increasingly expensive, and promises to escalate as yet another generation of veterans tries to heal its psychological wounds.

New hope for preventing the development of PTSD has been uncovered by Prof. Joseph Zohar of Tel Aviv University's Sackler Faculty of Medicine and the Sheba Medical Center, in collaboration with Prof. Hagit Cohen from Ben-Gurion University — and the key is a single dose of a common medication.

When a person suffers trauma, the body naturally increases its secretion of cortisone. Taking this natural phenomenon into account, Prof. Zohar set out to discover what a single extra dose of cortisone could do, when administered up to six hours after test subjects experienced a traumatizing event. The results, which will be published in the journal European Neuropsychopharmacology in October 2011, indicate that the likelihood that the patient will later develop PTSD is reduced by 60 percent.

Opening the window of opportunity

In most psychiatric conditions, it is impossible to establish a precise point of time at which the disorder manifested, Prof. Zohar says. But PTSD is unique in that is has an easily established timeline, beginning from the moment a patient experiences trauma. This makes PTSD eligible for treatment in the "golden hours" — a medical term that defines the precious few hours in which treatment can be most beneficial following a trauma, heart attack, stroke, or medical event. Receiving treatment in this window of opportunity can be critical.

In their animal models, Prof. Zohar and his fellow researchers first began treating PTSD in the window of opportunity up to six hours after a traumatic event. Two groups of rats were exposed to the smell of a cat, and one group was treated with cortisone after the event.

Following promising results with the rats, the researchers initiated a double-blind study in an emergency room, in which trauma victims entering the hospital were randomly assigned to receive a placebo or the cortisone treatment. Follow-up exams took place two weeks, one month, and three months after the event. Those patients who had received a shot of cortisone were more than sixty percent less likely to develop PTSD, they discovered.

Mimicking Mother Nature

When searching for a treatment method for PTSD, Prof. Zohar took his cue from Mother Nature. Most people who survive a traumatic experience don't develop PTSD because the cortisone that our body naturally produces protects us from developing the condition. But the right dose of cortisone at the right time could prove a source of secondary prevention for PTSD, he posited, helping along a natural process.

His approach also may circumvent the harm caused by dosing traumatised patients with other pharmaceuticals. In the emergency room, traumatized patients are often given medications such as Valium or Xanax, aimed at calming them down. In fact, Prof. Zohar says, these pills interfere with our natural and potent recovery process, hindering the secretion of cortisone.

"Looking at the long term effect, people who received these medications had a greater chance of developing PTSD than those who did not," he explains.

Prof. Zohar will expand this small pilot study with a $1.3 million dollar grant from the National Institute of Mental Health. He and his fellow researchers are teaming up with Prof. Rachel Yehuda of Mount Sinai Hospital in New York City, who will help them uncover the biochemical processes and underlying mechanisms of cortisone treatments for traumatized patients.

People who suffer from PTSD are haunted by their traumatic memories; for them, the past is always present, Prof. Zohar explains. Cortisone, given at the right dose at the right time, may alleviate the power of these traumatic memories by preventing their consolidation.

For more psychology and psychiatry news from Tel Aviv University, click here.

Original article: http://www.aftau.org/site/News2?page=NewsArticle&id=15343